Lobbying Activity Report

4710-22412

Designated Filer name: Hal Danchilla
Client: HLS Therapeutics Inc.
Associated registration: 1258-4710-1
Lobbying Activity date: 2022-11-08
Arranged a meeting: Yes
Posted date: 2022-12-12

Senior Public Office Holders who were lobbied in this activity: Alex McDonald, Senior Ministerial Assistant
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussing the benefits of Vascepa and its use as a preventative treatment for cardiovascular events in statin-treatment patients. Advocating for a product listing agreement through the British Columbia Ministry of Health for Vascepa. The intended outcome is to achieve a product listing agreement for Vascepa.
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
Date Modified: